New Zealand markets close in 5 hours 38 minutes

GSK plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
21.000.00 (0.00%)
At close: 02:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
30,740,000
30,328,000
29,324,000
24,696,000
24,354,000
Cost of revenue
8,592,000
8,565,000
9,554,000
8,163,000
7,929,000
Gross profit
22,148,000
21,763,000
19,770,000
16,533,000
16,425,000
Operating expenses
Research development
6,397,000
6,223,000
5,488,000
5,019,000
4,793,000
Selling general and administrative
9,329,000
9,385,000
8,372,000
7,070,000
7,437,000
Total operating expenses
15,395,000
14,418,000
13,041,000
11,655,000
11,847,000
Operating income or loss
6,753,000
7,345,000
6,729,000
4,878,000
4,578,000
Interest expense
688,000
725,000
826,000
764,000
847,000
Income before tax
5,512,000
6,064,000
5,628,000
3,599,000
5,170,000
Income tax expense
754,000
756,000
707,000
83,000
67,000
Income from continuing operations
4,758,000
5,308,000
4,921,000
3,516,000
5,103,000
Net income
4,484,000
4,928,000
14,956,000
4,385,000
5,749,000
Net income available to common shareholders
4,484,000
4,928,000
14,956,000
4,385,000
5,749,000
Basic EPS
1.50
1.22
3.71
1.10
1.44
Diluted EPS
1.48
1.20
3.66
1.08
1.43
Basic average shares
4,045,500
4,052,000
4,026,000
4,003,000
3,980,800
Diluted average shares
4,103,500
4,111,000
4,084,000
4,052,000
4,030,400